they're signaling molecules
Injectable GLP-1s bypass the gut entirely, delivering the drug straight into the body, which is why theyve been so effective and reliable, says Abbas Kanani, superintendent pharmacist at ChemistClick, a U.K.-based online pharmacy
Combined, these medications can intensify GI side effects and increase cardiovascular stress
While patients starting new therapies slowed in 2020, they are back up and new chronic Rxs 4% over the expected 2023 baseline
Current status: Phase 3 trials (expected to continue through 2025-2026) FDA approval timeline: Likely 2026-2027 at the earliest What needs to happen first: Complete Phase 3 trials in larger populations Gather long-term safety data FDA review and approval process Manufacturing scale-up So while the results are exciting, we're still a few years away from retatrutide being available by prescription
Some insurance plans cover specific medications